Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,276,257 papers from all fields of science
Search
Sign In
Create Free Account
CHGA gene
Known as:
vasostatin
, pancreastatin
, CHROMOGRANIN A
Expand
This gene plays a role in the modulation of the neuroendocrine system.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
CHGA protein, human
Chromogranin A
Chromogranin A (344-364) fragment
Chromogranin A measurement
Expand
Narrower (1)
CHGA wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
Chromogranin A is an autoantigen in type 1 diabetes
Brian D Stadinski
,
Thomas Delong
,
+11 authors
K. Haskins
Nature Immunology
2010
Corpus ID: 7490130
Autoreactive CD4+ T cells are involved in the pathogenesis of many autoimmune diseases, but the antigens that stimulate their…
Expand
Review
2007
Review
2007
The endocrine role for chromogranin A: A prohormone for peptides with regulatory properties
K. Helle
,
A. Corti
,
M. Metz-Boutigue
,
B. Tota
Cellular and Molecular Life Sciences
2007
Corpus ID: 30021923
Abstract.Chromogranin A (CgA) belongs to the granin family of uniquely acidic secretory proteins co-stored and co-secreted with…
Expand
Highly Cited
2002
Highly Cited
2002
Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies.
L. Anthony
,
E. Woltering
,
G. Espenan
,
M. Cronin
,
T. Maloney
,
K. McCarthy
Seminars in nuclear medicine
2002
Corpus ID: 33596984
Somatostatin and its analogues bind to somatostatin receptors (sst) 1 through 5 that are overexpressed in neuroendocrine…
Expand
Highly Cited
2001
Highly Cited
2001
Chromogranin A, an “On/Off” Switch Controlling Dense-Core Secretory Granule Biogenesis
Taeyoon Kim
,
J. Tao-Cheng
,
L. Eiden
,
Y. Loh
Cell
2001
Corpus ID: 15863805
Review
2000
Review
2000
Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation.
A. Griffioen
,
G. Molema
Pharmacological Reviews
2000
Corpus ID: 850425
Angiogenesis, or the formation of new blood vessels out of pre-existing capillaries, is a sequence of events that is fundamental…
Expand
Highly Cited
1999
Highly Cited
1999
Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth.
S. Pike
,
L. Yao
,
+10 authors
G. Tosato
Blood
1999
Corpus ID: 24979445
Several angiogenesis inhibitors are fragments of larger proteins that are themselves not active as angiogenesis inhibitors…
Expand
Highly Cited
1998
Highly Cited
1998
Vasostatin, a Calreticulin Fragment, Inhibits Angiogenesis and Suppresses Tumor Growth
S. Pike
,
L. Yao
,
+8 authors
G. Tosato
Journal of Experimental Medicine
1998
Corpus ID: 838306
An endothelial cell inhibitor was purified from supernatant of an Epstein-Barr virus–immortalized cell line and identified as…
Expand
Highly Cited
1997
Highly Cited
1997
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
S. Mahata
,
Daniel T O'connor
,
+5 authors
R. Parmer
Journal of Clinical Investigation
1997
Corpus ID: 13970254
Catecholamine secretory vesicle core proteins (chromogranins) contain an activity that inhibits catecholamine release, but the…
Expand
Highly Cited
1992
Highly Cited
1992
The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels
S. Aardal
,
K. Helle
Regulatory Peptides
1992
Corpus ID: 27841422
Highly Cited
1987
Highly Cited
1987
The primary structure of human chromogranin A and pancreastatin.
D. Konecki
,
U. Benedum
,
H. Gerdes
,
Wieland B. Huttnerz
Journal of Biological Chemistry
1987
Corpus ID: 32014424
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE